bluebird bio Competitors or Alternatives

bluebird bio's top competitors include Sangamo, Intellia and CRISPR.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

bluebird bio's company profile

Andrew Obenshain

CEO

73/100
520
$821.4M
$83.8M
1
bluebird bio's Competitor - Sangamo logo

Sandy Macrae

President & CEO

68/100
480
$71.5M
$57.8M
2
bluebird bio's Competitor - Intellia logo

John Leonard

President & CEO

82/100
600
$883M
$57.9M
3
bluebird bio's Competitor - CRISPR logo

Samarth Kulkarni

CEO

94/100
393
$183M
$37.3M
4
bluebird bio's Competitor - Elcelyx Therapeutics logo

Alain D. Baron

President & CEO

79/100
1 - 25
$93.3M
$100K - 5M
5
bluebird bio's Competitor - Gelesis logo

Yishai Zohar

Founder & CEO

61/100
93
$263M
$12.1M

bluebird bio VS Sangamo

Sangamo is the biggest rival of bluebird bio. Sangamo was founded in 1995, and its headquarters is in Brisbane, California. Sangamo operates in the Biotechnology industry. Sangamo has 40 fewer employees than bluebird bio.

bluebird bio VS Intellia

Intellia has been one of bluebird bio's top competitors. Intellia is a Public company that was founded in Cambridge, Massachusetts in 2014. Intellia is in the Biotechnology industry. Intellia has 80 more employees vs. bluebird bio.

bluebird bio VS CRISPR

CRISPR is bluebird bio's #3 rival. CRISPR was founded in 2013 in Zug, Zug. CRISPR is in the Biotechnology field. CRISPR generates $46.5M less revenue than bluebird bio.

Frequently Asked Questions about bluebird bio

  1. Who are bluebird bio's top competitors?

    bluebird bio's top 3 competitors are Sangamo, Intellia, CRISPR.
  2. Who is similar to bluebird bio?

    Sangamo is the most similar to bluebird bio. Intellia and CRISPR are also similar to bluebird bio.
  1. Are bluebird bio and Sangamo competitors?

    Yes, Sangamo is one of bluebird bio’s top competitors.